Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model.
The therapeutic potential of cannabis and cannabinoids.
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis.
The Communicative Participation Item Bank (CPIB): Item bank calibration and development of a disorder-generic short form.
Using Functional Electrical Stimulation Mediated by Iterative Learning Control and Robotics to Improve Arm Movement for People With Multiple Sclerosis.
Bilateral idiopathic optic neuritis in pregnancy.
Cannabis for spasticity and multiple sclerosis
Fingolimod after natalizumab and the risk of short-term relapse.
Detecting clinically-relevant changes in progressive multiple sclerosis.
Reliability and Validity of Ratings of Perceived Exertion in Persons with Multiple Sclerosis.
Cognitive rehabilitation in Multiple sclerosis.
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.
Teva targets $4 billion lupus market with laquinimod study
JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
Development of a high-resolution fat and CSFsuppressed optic nerve DTI protocol at 3T: application in multiple sclerosis.
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.
Brain size and white matter content of cerebrospinal tracts determine the upper cervical cord area: evidence from structural brain MRI.
Validation survey of the impact of urinary incontinence (IIQ-7) and inventory of distress urogenital (UDI-6) - the short scales - in patients with multiple sclerosis.
Pages
« first
‹ previous
…
210
211
212
213
214
215
216
217
218
…
next ›
last »